<html>
<head>PUBMED IDs for SLC39A13</head>
<body bgcolor='#C5F0F2'><h1>SLC39A13</h1><a href='https://pubmed.ncbi.nlm.nih.gov/18513683/'>Spondylocheiro dysplastic form of the Ehlers-Danlos syndrome--an autosomal-recessive entity caused by mutations in the zinc transporter gene SLC39A13.</a> June 3  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/21739577/'>Mutational analysis of 12 patients with the phenotype of Ehlers-Danlos syndrome type VIB shows no linkage to the zinc transporter gene SLC39A13.</a> December 13  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21917916/'>Biochemical characterization of human ZIP13 protein: a homo-dimerized zinc transporter involved in the spondylocheiro dysplastic Ehlers-Danlos syndrome.</a> January 6  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/23213233/'>Promotion of vesicular zinc efflux by ZIP13 and its implications for spondylocheiro dysplastic Ehlers-Danlos syndrome.</a> March 1  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/26091878/'>De novo mutations from sporadic schizophrenia cases highlight important signaling genes in an independent sample.</a> May 3  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26091847/'>Genetic polymorphisms of pharmacogenomic VIP variants in the Uygur population from northwestern China.</a> March 25  2015<br></body></html>
